نتایج جستجو برای: rhg csf

تعداد نتایج: 28517  

Journal: :Blood 2004
Kouji Kusano Shinji Ebara Koichi Tachibana Tadahiro Nishimura Susumu Sato Tomoaki Kuwaki Tadayoshi Taniyama

Granulocyte colony-stimulating factor (G-CSF) stimulates the proliferation of bone marrow granulocytic progenitor cells and promotes their differentiation into granulocytes. G-CSF is therefore an important component of immune defense against pathogenic microorganisms: recombinant human G-CSF (rhG-CSF) is used to treat patients with a variety of neutropenias. In the present study, we screened ap...

Journal: :Blood 1992
C Zeidler L Kanz F Hurkuck K L Rittmann I Wildfang T Kadoya T Mikayama L Souza K Welte

We have studied the in vivo effects of recombinant human interleukin-6 (rhIL-6) on hematopoiesis in eight healthy and nine irradiated cynomolgus monkeys. Of the healthy animals, three received rhIL-6 alone (10 micrograms/kg/d, subcutaneously [SC]), one received rhIL-6 in combination with rhIL-3 (10 micrograms/kg/d, SC), one received rhIL-6 in combination with recombinant cynomolgus granulocyte-...

Journal: :Haematologica 1994
M C Miggiano F Gherlinzoni G Visani A Belardinelli P Ricci G Rosti P Mazza M R Motta S Rizzi R M Lemoli

BACKGROUND Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. METHODS The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients recei...

2003
Hans von der Maase Lena Specht Grete Krag Jacobsen Anders Jakobsen Ebbe Lindegaard Madsen Mogens Pedersen Mikael Rrth Henrik Schultz

17. Morstyn G, Campbell L, Lieschke G, et al. Treatment of chemotherapy induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and durationof therapy.3 Clin Oncoll989,7,1554-1562. Brugger W, Bross KJ, Lindemann A, Kanz L, Mertelsmann M. Role of hematopoietic growth factor combinations in experimental and clinical oncology. Semin Oncoll...

2003
R A. C. A.

Splenectomized mice treated for 7 days with pegylated recombinant rat stem cell factor (rrSCF-PEG) showed a dosedependent increase in peripheral blood progenitor cells (PBPC) that have enhanced in vivo repopulating potential. A dose of rrSCF-PEG at 25 pg/kg/d for 7 days produced no significant increase in PBPC. However, when this dose of rrSCF-PEG was combined with an optimal dose of recombinan...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید